Parexel recruits top FDA oncology expert Amy McKee for new R&D initiative
Amy McKee, one of Richard Pazdur’s close allies in building out the Oncology Center of Excellence at the FDA, has left the agency to help companies navigate a regulatory landscape she helped shape.
As VP of regulatory consulting services at Parexel, she joins a nascent oncology initiative dedicated to connecting different business units to work up development plans — not unlike how she created a communications structure for different offices across the FDA’s centers for drug, biologics and devices.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.